# Mathematical model for empirically optimizing large scale production of soluble protein domains

- Eisuke Chikayama
^{1}Email author, - Atsushi Kurotani
^{1}, - Takanori Tanaka
^{1}, - Takashi Yabuki
^{1}, - Satoshi Miyazaki
^{1, 2}, - Shigeyuki Yokoyama
^{1, 2}and - Yutaka Kuroda
^{3}Email author

**11**:113

**DOI: **10.1186/1471-2105-11-113

© Chikayama et al; licensee BioMed Central Ltd. 2010

**Received: **25 August 2009

**Accepted: **1 March 2010

**Published: **1 March 2010

## Abstract

### Background

Efficient dissection of large proteins into their structural domains is critical for high throughput proteome analysis. So far, no study has focused on mathematically modeling a protein dissection protocol in terms of a production system. Here, we report a mathematical model for empirically optimizing the cost of large-scale domain production in proteomics research.

### Results

The model computes the expected number of successfully producing soluble domains, using a conditional probability between domain and boundary identification. Typical values for the model's parameters were estimated using the experimental results for identifying soluble domains from the 2,032 Kazusa HUGE protein sequences. Among the 215 fragments corresponding to the 24 domains that were expressed correctly, 111, corresponding to 18 domains, were soluble. Our model indicates that, under the conditions used in our pilot experiment, the probability of correctly predicting the existence of a domain was 81% (175/215) and that of predicting its boundary was 63% (111/175). Under these conditions, the most cost/effort-effective production of soluble domains was to prepare one to seven fragments per predicted domain.

### Conclusions

Our mathematical modeling of protein dissection protocols indicates that the optimum number of fragments tested per domain is actually much smaller than expected *a priori*. The application range of our model is not limited to protein dissection, and it can be utilized for designing various large-scale mutational analyses or screening libraries.

## Background

Comprehensive elucidation of the functional and structural units present in the proteome is the ultimate goal in proteomics research, and it is expected to provide basic data for a rational understanding of complex biological systems. As proteomics studies are being pursued [1–5], the development of efficient methodologies for dissecting long protein sequences into their domains is becoming critical. This is because biologically important proteins are often large and are thus difficult to express, purify and characterize in a high throughput manner [6].

Experimental approaches for dissecting proteins are usually based on limited proteolysis, which has been used to explore protein domain boundaries [7]. Although experimental protein dissection methods have been extended to high throughput protocols [8–10], they remain essentially expensive and time-consuming.

Computer-aided protein dissection approaches are relatively inexpensive, and thus represent promising methodologies that have practical values in high throughput proteomics research. The strategies for predicting novel domain regions, without sequence similarity to domain databases, can be categorized into two classes. The first strategy aims at directly predicting domain regions by analyzing various sequence properties of the foldable region (e.g., see Refs [11, 12]). The second strategy is to first predict the location of the domain boundaries and then use this information to infer the domain's position (e.g., see Refs [13, 14]). Both strategies are essential to efficiently identify novel protein domains.

Proteomics projects require the identification of soluble and well behaved proteins enabling a fast structural/functional analysis [15]. Solubility is an important criterion strongly reflecting a protein's suitability for biophysical characterization. It can be readily monitored, and solubility assays are thus applied to large-scale studies [16]. Furthermore, when solubility is used to assess domain dissection experiments, it appears that a large fraction of soluble fragments are indeed well folded as assessed by NMR [17, 18].

So far, reports of high throughput protein domain production protocols have mainly focused on their development and on optimizing individual experimental steps of the protocols. No study has mathematically modelled a protein domain production protocol in terms of a production system, and thus substantial room for cost-optimization through mathematical modeling remains available. In this report, we present a mathematical model for empirically optimizing large-scale protein domain production. Our model conceptually divides domain predictions into the prediction of the domain region and its boundary, and it computes the expected number of successfully produced soluble domains, using a conditional probability between these two events. We estimated the model parameters using the experimental results from a computer-aided identification of novel soluble protein domains from Kazusa HUGE protein sequences, in which 436 fragments, encoding 36 novel putative domains with slightly different domain boundaries, were expressed by using an E-coli-based cell-free system, and their solubilities were assessed with SDS-PAGE gels.

## Results and Discussion

### Mathematical model of protein dissection

^{c}), respectively (Figure 1a). S and S

^{c}are mutually exclusive sets, and S

^{c}is the complement of S. We define a "soluble domain" as a domain that encodes at least one soluble fragment. A fragment that is associated with a "soluble domain" is an element of the set D (Figure 1b). According to this definition, some fragments encoding a soluble domain may be insoluble. The fragments encoding non-soluble domains, i.e., predicted domains for which all fragments are insoluble, are elements of the set D

^{c}(Figure 1b and 1e). Practically, a domain is defined as non-soluble if all of the tested fragments associated with a given domain (in our experiment, 9 per domain, on average) are insoluble. D and D

^{c}are also mutually exclusive sets, and their elements are fragments (not domains). The above classification yields four fragment categories (Figure 1c): S ∩ D (Soluble domain fragments with correct N and C termini), S

^{c}∩ D (Insoluble fragments encoding a soluble domain, presumably because of incorrect termini), S ∩ D

^{c}(Soluble fragment encoding a non-domain or a failed domain prediction; this set is obviously empty), and S

^{c}∩ D

^{c}(Insoluble fragment encoding a non-domain; all elements of D

^{c}obviously belong to S

^{c}).

*p*(S), is expressed as

^{c}is empty and all sets are exclusive.

*p*(D) is thus related to

*p*(S) as

*p*(S|D) is the conditional probability of obtaining a soluble fragment of a soluble domain. When

*p*(S) and

*p*(S|D) are given, the probability of successfully predicting the existence of a soluble domain is calculated as

Note that Eqs. 1-3 are direct consequences from probability rules for independent sets, without any approximations or assumptions.

*E*

_{domain}, by assuming average probability values over all of the protein domains examined in the experiment. Our model examines

*M*protein domains and generates

*N*fragments per domain. According to this model, the expected number of soluble domains,

*E*

_{domain}, is given by:

where *M* and *N* are, respectively, the number of domains and the number of fragments per domain that are assessed. When the total number of fragments (*MN*) is held *constant*, the probability of obtaining one or more soluble fragments, *P*_{
N
}, is a function of *N* and *p*(S|D). The explicit form of *P*_{
N
}depends on the experimental setting, and is derived in the next section for two specific cases.

*MN*+

*Mr*, where

*r*is the ratio between the supplemental cost of analyzing a fragment from a new domain and that of analyzing a new fragment from the current domain. Keeping the total cost constant [

*M*(

*N*+

*r*) =

*constant*] yields:

### Derivation of *P*_{
N
}for two basic experimental settings

*P*

_{ N }for two basic types of experimental settings. In the first one, the generation of

*N*fragments occurs by independent events (multiple copy case). This situation occurs in genetic screening experiments, where

*N*fragments per domain are randomly selected and tested, allowing multiple copies of the same fragment to be tested. In this case, the mathematical expression for

*P*

_{ N }is simply calculated as:

where *P*_{
N
}is the probability of obtaining one or more soluble fragments of a soluble domain when *N* fragments are simultaneously tested. *F* is the (average) number of all of the testable (assessable) fragments, and *f* is the (average) number of soluble fragments associated to a domain.

*N*fragments are generated, but each fragment is selected only once (single copy case). This situation occurs when the fragments are identifiable, such as in our pilot experiment with the Kazusa sequences.

*P*

_{ N }is derived by using a hypergeometric distribution (

*P*

_{N}

^{C}), which describes the probability of obtaining no soluble elements when

*N*elements are drawn without replacement from a finite population of

_{ F }

*C*

_{ N }elements (

_{ m }

*C*

_{ n }indicates the binomial coefficient for choosing

*n*elements from

*m*elements).

*P*

_{ N }is given by

where *P*_{N}^{C} is the probability of obtaining no soluble fragments when *N* fragments are tested (see Additional file 1 for detail.) A JavaScript program, implementing Eqs. 5-7, is available in Additional file 2.

### Parameter estimation from a pilot experiment with Kazusa HUGE domains

The application range of our mathematical model is not restricted to describe or analyze a specific domain prediction method (such as Armadillo[19], or PRODOM[20]), or experimental procedure (E-coli strains, or cell free systems). The specific settings/protocols are taken into account by adjusting or optimizing the values of the model's parameters. Here, we will estimate typical values for the parameters using the solubility of protein domains predicted in the Kazusa HUGE protein sequences [21].

*p*(S) and

*p*(S

^{C}) = 0.48; Table 1) of the fragments were soluble when 9 fragments were tested on average (instead of 12 when all 436 of the fragments are considered).

*p*(S|D), which is the conditional probability of correctly predicting a soluble fragment of a soluble domain, is 0.63 (111 fragments/175 fragments). The calculation of

*p*(D) from Eq. 3, using the obtained values of

*p*(S) and

*p*(S|D), generates 0.81. Substituting 0.81 and 9 for

*p*(D) and

*N*, respectively, in Eq. 4, yields

*E*

_{domain}/

*M*as 0.81, which is equal to

*p*(D), within rounding error, since

*P*

_{ N }is almost 1 when

*N*= 9. The discrepancy from the above experimental

*E*

_{domain}/

*M*value of 0.75 (Figure 3), is due to the use of average values. Indeed, for 6 domains, all of the fragments were soluble, and 12 domains yielded a mixture of soluble and insoluble fragments (Figure 4a). However, the corrections appear to be modest (less than 10%) and will not significantly affect the following discussion (the calculation with non-averaged

*f*and

*F*values is discussed in Additional file 1).

Estimated model parameters

D | D | ALL | |
---|---|---|---|

S | 0.52 ± 0.03 | 0.00 ± 0.00 | 0.52 ± 0.03 |

S | 0.29 ± 0.03 | 0.19 ± 0.03 | 0.48 ± 0.03 |

ALL | 0.81 ± 0.03 | 0.19 ± 0.03 | 1.00 |

Let us perform a simple mathematical simulation to assess the discrepancy between the above experimental and calculated values of 0.75 and 0.81. The discrepancy can be resolved by setting the number of tested fragments per domain to, for example, 10, and by uniformly using for all domains the above experimentally determined average values of 0.75 and 0.52 for *p*(D) and *p*(S), respectively. As a result, 240 fragments are produced, corresponding to 24 domains, of which 6 do not yield any soluble fragment, since *p*(D) = 0.75. Since *p*(S) = 0.52, 124.8 fragments are soluble. These soluble fragments are uniformly distributed among the 18 domains, and thus 6.93 (7) fragments per domain out of 10 fragments are soluble, which yields 0.693 for *p*(S|D). Using Eq. 3, *p*(D) = 0.52/0.693 = 0.75, and thus *p*(D) *P*_{
N
}= 0.75 * {1 - (1 - 0.693)^{10} = 0.75, which is equal, within rounding error, to the experimentally determined value of 0.75 (18 domains out of 24).

In the present experiment, 12 domains (221 fragments) could not be analyzed because of failure to express a fragment with a correct molecular weight, or to assess the solubility, which obviously indicates that the efficiency of our automated protein expression system has room for improvement. These 12 domains can be included in the analysis and will give lower (or upper) limits by considering them as insoluble (or soluble) domains. The inclusion yields 50% (18/36) and 25% (111/436) for, respectively, the lower probability limit of predicting the domain existence and that of predicting a soluble fragment for 12 tested fragments, on average. Similarly, some or all of the 6 domains that were considered insoluble in the above discussion might turn out to be soluble if more fragments were tested.

### Effect of the cleavage site on the solubility of the dissected domain

The effect of the cleavage site on the solubility of the dissected domain was also examined (Additional file 3). All of the fragments corresponding to 6 domains (KIAA0190.21-227, KIAA0309.483-717, KIAA1142.35-97, KIAA1256.13-117, KIAA1416.55-202, and KIAA1459.745-848) were soluble (all-soluble class); while KIAA0067.1143-1295, KIAA0175.480-651, KIAA0190.436-653, KIAA0277.120-349, KIAA0641.76-352, and KIAA1338.180-406 were insoluble (all-insoluble class), indicating a failed domain prediction. On the other hand, the solubility of the remaining 12 domains was dependent on the position of the cleavage site, and both soluble and insoluble fragments were produced, depending on slight shifts of the cleavage residue at each of the N- and C- domain terminal ends (soluble+insoluble class). The effects of the cleavage site within the window were also examined. Except for site 4, which corresponded to either the N or C protein terminus, no differences in the yields of soluble fragments were observed (Figure 4b). Note that the small number of cleavage at site 4 simply results from the fact that not all domains were located at the N or C protein terminus.

### Optimum fragment number per domain

*p*(D) is independent of

*N*, we can simplify Eq. 5, and examine the normalized expected number of soluble domains,

*e*

_{domain}, instead of

*E*

_{domain}:

*P*

_{ N }can be computed with either Eq. 6 or 7, since no noticeable difference will occur for practical purposes (for most cases, within a few percent error; see Figure 5). When no set-up cost is present (

*r*= 0),

*e*

_{domain}is a monotone decreasing function of

*N*(Figure 5a). Thus, one fragment per predicted domain will optimize the number of soluble domains (

*N*

_{optimum}= 1). This is analytically demonstrated by showing that

*N*

_{optimum}is the solution of a transcendental equation with a unique solution (A mere exception occurs for

*f*= 1 when the single copy per fragment model is used; Figure 5a and Additional file 1).

Set-up costs are typically generated by the purchase of new chemicals associated with the examination of a new domain, and may, for example include the clone's cost, from which the domain fragments are prepared by PCR. Large *r* values may occur in a genetic screening-type experiment, where the cost of assessing a new fragment is small as compared to that of starting a new experiment with a new domain. For *r* > 0, *e*_{domain} is not a monotone decreasing function of *N*, but reaches a maximum at *N* = *N*_{optimum} (Figure 5b). The value of *N*_{optimum} increases for increasing values of *r* (Figure 5b).

As an example, using the values derived from our pilot experiment [*p*(S|D) = 0.63 (= *f*/*F*)] and assuming that *r* = 10, we find that testing three fragments per predicted domain would yield more soluble domains than just one, for the same total cost (Figure 5b). Note that, as *r* increases, the peak broadens and the maximum *e*_{domain} value, *e*_{domain} (*N*_{optimum}), becomes smaller (Figure 5b). Thus, in practical terms, the *e*_{domain} dependence on *N* is small for large *r* and it becomes less important to accurately determine *N*_{optimum}. Finally, we note that in Eq. 6 (multiple copy model), *e*_{domain} depends on the ratio of *f* and *F*, which is the probability of finding the correct cleavage sites, but it does not depend directly on *F* alone, which is the total number of possible cleavage sites. The direct dependency on *F* alone is also minimal when the single copy model (Eq. 7) is used (Figure 5b).

Insight into a wide range of experimental settings can be obtained by analyzing the behavior of *N*_{optimum} for several values of *p*(S|D) and *r* (Figure 5c). For example, we find that *N*_{optimum} increases with decreasing values of *p*(S|D), which is intuitively sensible, since a smaller *p*(S|D) requires a larger number of trials for finding the termini residues that yield a soluble domain fragment. *N*_{optimum} is between 1 and 4 for *r* = 1 and a broad range of *p*(S|D) > 0.1, which covers most experimental settings including our pilot experiment using Kazusa sequences. A *p*(S|D) > 0.1 would also cover typical domain prediction tools such as Armadillo prediction, which has a *p*(S|D) value estimated by cross validation method between 0.3 and 0.5 [19]. Finally, for a typical value of *r* = 10 and *p*(S|D) > 0.5, *N*_{optimum} is between 1 and 3; and for *p*(S|D) = 0.63, *N*_{optimum} is 7 fragments, even for *r* = 1,000 (i.e., a very large set-up cost).

## Conclusions

We have presented a novel mathematical formulation for optimizing large-scale protein domain production experiments. Our model demonstrated that the testing of one to seven fragments per domain will fit most high throughput protein domain production experiments. The probabilistic approach presented here is not limited to protein domain production, and it can be readily modified and applied for designing various types of large-scale mutational analyses or screening libraries.

## Methods

### Computational protein dissection

Domains were computationally predicted from 2,032 Kazusa HUGE [21] protein sequences (KIAA0001-KIAA2033), using ProteoMix [22], an integrated protein sequence analysis system. The ProteoMix analysis included PASS [23] for domain predictions, and DLiP [24] and DLP [13, 25] for domain linker predictions. PASS analyses were performed with default parameters (E-value = 1e-7, Cut-off homologues = 10); DLP with default (Threshold = 0.5, Cut-off = 0.5, Ignored terminal length = 0, Window = 19, Minimum difference = 0.05); and DLiP with no BLAST option. The other tools were HMMTOP [26] and MEMSAT [27] for trans-membrane region prediction, and BLAST [28] for removing domains homologous to structurally known protein sequences derived from the Protein Data Bank [29]. We obtained 269 putative domains according to the following rules: A putative domain was identified when it was a PASS predicted domain region whose boundary overlapped either with one of the full-length protein termini, or with a domain boundary predicted with either DLiP and DLP results (predicted domain linker regions) within ± 25 residues. We also required that the putative domain did not include transmembrane regions, as predicted by HMMTOP or MEMSAT with default parameters, to remove the inherently insoluble domains; and putative domains with sequence identities higher than 30% to PDB protein sequences were also removed. Finally, we choose 27 domains by visually inspecting the consistency among the prediction's tools, domain's, and domain linker's sizes. In addition, we completed this set with 9 domains predicted in one of the putative multi-domain protein sequences that contained one of the above 27 domains. This yielded 36 domains that were assessed experimentally. For each of the 36 dissected domains, a maximum of 20 fragments per domain, resulting in a total of 436 fragments, were designed by combining the results of PASS, DLiP, and DLP, and our termini selection rule (see Figure 2b). This resulted in a 30 residue N- or C- terminal end window (corresponding to 900 fragments per domain) on average, from which the termini residues were selected.

### Experimental assessment

The cDNA clones for the selected 36 protein domains (436 fragments) were kindly provided by Kazusa DNA Research Institute (Kisaradsu, Japan). The corresponding protein fragments were expressed using an E-coli based cell-free system and were purified as described [30]. The fragments were classified as soluble, insoluble, and not applicable, according to an SDS-PAGE analysis of the supernatant and precipitate fractions. The soluble fragments were defined as the fragments that remained in the supernatant after centrifugation. The fragments that were present in the SDS-PAGE of the precipitate, but absent from the supernatant after centrifugation, were defined as insoluble fragments. All other fragments were classified as not applicable, which included all kinds of experimental obstacles, such as unsuccessful PCR, wrong cDNA sequences, no expression or ambiguous SDS-PAGE results.

## Declarations

### Acknowledgements

We thank Dr. Takanori Kigawa and the members of the GSC Protein Research Group for the cell-free production and screening system, and Kazusa Research Institute for the HUGE cDNA resources. This work was supported by the RIKEN Structural Genomics/Proteomics Initiative (RSGI), the National Project on Protein Structural and Functional Analyses, from MEXT.

## Authors’ Affiliations

## References

- Chandonia JM, Brenner SE: The impact of structural genomics: Expectations and outcomes.
*Science*2006, 311(5759):347–351. 10.1126/science.1121018View ArticlePubMedGoogle Scholar - Kouranov A, Xie L, de la Cruz J, Chen L, Westbrook J, Bourne PE, Berman HM: The RCSB PDB information portal for structural genomics.
*Nucleic Acids Res*2006, (34 Database):D302–305. 10.1093/nar/gkj120Google Scholar - Terwilliger TC, Stuart D, Yokoyama S: Lessons from structural genomics.
*Annu Rev Biophys*2009, 38: 371–383. 10.1146/annurev.biophys.050708.133740View ArticlePubMedPubMed CentralGoogle Scholar - Zhang C, Kim SH: Overview of structural genomics: from structure to function.
*Current Opinion in Chemical Biology*2003, 7(1):28–32. 10.1016/S1367-5931(02)00015-7View ArticlePubMedGoogle Scholar - Dessailly BH, Nair R, Jaroszewski L, Fajardo JE, Kouranov A, Lee D, Fiser A, Godzik A, Rost B, Orengo C: PSI-2: structural genomics to cover protein domain family space.
*Structure*2009, 17(6):869–881. 10.1016/j.str.2009.03.015View ArticlePubMedPubMed CentralGoogle Scholar - Card PB, Gardner KH: Identification and optimization of protein domains for NMR studies.
*Methods Enzymol*2005, 394: 3–16. 10.1016/S0076-6879(05)94001-9View ArticlePubMedGoogle Scholar - Fontana A, de Laureto PP, Spolaore B, Frare E, Picotti P, Zambonin M: Probing protein structure by limited proteolysis.
*Acta Biochim Pol*2004, 51(2):299–321.PubMedGoogle Scholar - Christ D, Winter G: Identification of protein domains by shotgun proteolysis.
*J Mol Biol*2006, 358(2):364–371. 10.1016/j.jmb.2006.01.057View ArticlePubMedGoogle Scholar - Dokudovskaya S, Williams R, Devos D, Sali A, Chait BT, Rout MP: Protease accessibility laddering: a proteomic tool for probing protein structure.
*Structure*2006, 14(4):653–660. 10.1016/j.str.2006.02.006View ArticlePubMedGoogle Scholar - Gao X, Bain K, Bonanno JB, Buchanan M, Henderson D, Lorimer D, Marsh C, Reynes JA, Sauder JM, Schwinn K,
*et al*.: High-throughput limited proteolysis/mass spectrometry for protein domain elucidation.*J Struct Funct Genomics*2005, 6(2–3):129–134. 10.1007/s10969-005-1918-5View ArticlePubMedGoogle Scholar - Marsden RL, McGuffin LJ, Jones DT: Rapid protein domain assignment from amino acid sequence using predicted secondary structure.
*Protein Sci*2002, 11(12):2814–2824. 10.1110/ps.0209902View ArticlePubMedPubMed CentralGoogle Scholar - Wheelan SJ, Marchler-Bauer A, Bryant SH: Domain size distributions can predict domain boundaries.
*Bioinformatics*2000, 16(7):613–618. 10.1093/bioinformatics/16.7.613View ArticlePubMedGoogle Scholar - Miyazaki S, Kuroda Y, Yokoyama S: Characterization and prediction of linker sequences of multi-domain proteins by a neural network.
*J Struct Funct Genomics*2002, 2(1):37–51. 10.1023/A:1014418700858View ArticlePubMedGoogle Scholar - Suyama M, Ohara O: DomCut: prediction of inter-domain linker regions in amino acid sequences.
*Bioinformatics*2003, 19(5):673–674. 10.1093/bioinformatics/btg031View ArticlePubMedGoogle Scholar - Niwa T, Ying BW, Saito K, Jin W, Takada S, Ueda T, Taguchi H: Bimodal protein solubility distribution revealed by an aggregation analysis of the entire ensemble of Escherichia coli proteins.
*Proceedings of the National Academy of Sciences of the United States of America*2009, 106(11):4201–4206. 10.1073/pnas.0811922106View ArticlePubMedPubMed CentralGoogle Scholar - Cabantous S, Waldo GS: In vivo and in vitro protein solubility assays using split GFP.
*Nature Methods*2006, 3(10):845–854. 10.1038/nmeth932View ArticlePubMedGoogle Scholar - Folkers GE, van Buuren BN, Kaptein R: Expression screening, protein purification and NMR analysis of human protein domains for structural genomics.
*J Struct Funct Genomics*2004, 5(1–2):119–131. 10.1023/B:JSFG.0000029200.66197.0cView ArticlePubMedGoogle Scholar - Hondoh T, Kato A, Yokoyama S, Kuroda Y: Computer-aided NMR assay for detecting natively folded structural domains.
*Protein Science*2006, 15(4):871–883. 10.1110/ps.051880406View ArticlePubMedPubMed CentralGoogle Scholar - Dumontier M, Yao R, Feldman HJ, Hogue CW: Armadillo: domain boundary prediction by amino acid composition.
*J Mol Biol*2005, 350(5):1061–1073. 10.1016/j.jmb.2005.05.037View ArticlePubMedGoogle Scholar - Corpet F, Servant F, Gouzy J, Kahn D: ProDom and ProDom-CG: tools for protein domain analysis and whole genome comparisons.
*Nucleic Acids Res*2000, 28(1):267–269. 10.1093/nar/28.1.267View ArticlePubMedPubMed CentralGoogle Scholar - Kikuno R, Nagase T, Nakayama M, Koga H, Okazaki N, Nakajima D, Ohara O: HUGE: a database for human KIAA proteins, a 2004 update integrating HUGEppi and ROUGE.
*Nucleic Acids Res*2004, (32 Database):D502–504. 10.1093/nar/gkh035Google Scholar - Chikayama E, Kurotani A, Kuroda Y, Yokoyama S: ProteoMix: an integrated and flexible system for interactively analyzing large numbers of protein sequences.
*Bioinformatics*2004, 20(16):2836–2838. 10.1093/bioinformatics/bth276View ArticlePubMedGoogle Scholar - Kuroda Y, Tani K, Matsuo Y, Yokoyama S: Automated search of natively folded protein fragments for high-throughput structure determination in structural genomics.
*Protein Sci*2000, 9(12):2313–2321. 10.1110/ps.9.12.2313View ArticlePubMedPubMed CentralGoogle Scholar - Tanaka T, Yokoyama S, Kuroda Y: Improvement of domain linker prediction by incorporating loop-length-dependent characteristics.
*Biopolymers*2006, 84(2):161–168. 10.1002/bip.20361View ArticlePubMedGoogle Scholar - Miyazaki S, Kuroda Y, Yokoyama S: Identification of putative domain linkers by a neural network - application to a large sequence database.
*BMC Bioinformatics*2006, 7(1):323. 10.1186/1471-2105-7-323View ArticlePubMedPubMed CentralGoogle Scholar - Tusnady GE, Simon I: The HMMTOP transmembrane topology prediction server.
*Bioinformatics*2001, 17(9):849–850. 10.1093/bioinformatics/17.9.849View ArticlePubMedGoogle Scholar - Jones DT, Taylor WR, Thornton JM: A model recognition approach to the prediction of all-helical membrane protein structure and topology.
*Biochemistry*1994, 33(10):3038–3049. 10.1021/bi00176a037View ArticlePubMedGoogle Scholar - Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs.
*Nucleic Acids Res*1997, 25(17):3389–3402. 10.1093/nar/25.17.3389View ArticlePubMedPubMed CentralGoogle Scholar - Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank.
*Nucleic Acids Res*2000, 28(1):235–242. 10.1093/nar/28.1.235View ArticlePubMedPubMed CentralGoogle Scholar - Kigawa T, Yabuki T, Yoshida Y, Tsutsui M, Ito Y, Shibata T, Yokoyama S: Cell-free production and stable-isotope labeling of milligram quantities of proteins.
*FEBS Lett*1999, 442(1):15–19. 10.1016/S0014-5793(98)01620-2View ArticlePubMedGoogle Scholar

## Copyright

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.